Celldex breast cancer drug shrinks some tumors: study
(Reuters) - Interim results from a mid-stage trial of Celldex Therapeutics Inc's experimental drug showed trends toward reducing tumors in patients with advanced breast cancer, with rates improving for those patients with high levels of a key protein. (Source: Reuters: Health)

Non-Hodgkin Lymphoma Risk Factors During Early Life
Older maternal age, low birth order, male gender, family characteristics, and high fetal growth are all factors that increase the risk of developing early life non-Hodgkin lymphoma (NHL), say researchers. According to the study, published in the Journal of National Cancer Institute, the incidence of NHL has increased significantly over the last 5 decades. Although the overall incidence began to stabilize among adults, it has continued growing in children, adolescents, and young adults. As a result, Casey Crump, M.D., Ph.D... (Source: Health News from Medical News Today)